Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Retinal Vein Occlusion (CRVO)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableUnknownNCT01531842
What this trial is testing

A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye

Who this might be right for
Central Retinal Vein OcclusionChoroidal NeovascularizationAge-related Macular Degeneration+1 more
Mid Atlantic Retina 30
Not applicableStudy completedNCT04137120
What this trial is testing

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice

Who this might be right for
Retinal Disease
Bayer 73
Not applicableStudy completedNCT02585401
What this trial is testing

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Who this might be right for
Age-related Macular Degeneration (AMD)Central Retinal Vein Occlusion (CRVO)Diabetic Macular Edema (DME)
Bayer 99
Early research (Phase 1)Ended earlyNCT00969293
What this trial is testing

Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Fovea Pharmaceuticals SA 11
Post-approval studies (Phase 4)UnknownNCT01827722
What this trial is testing

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Valley Retina Institute 45
Not applicableStudy completedNCT02880644
What this trial is testing

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept

Who this might be right for
Retinal Vein Occlusion
Centre Hospitalier Intercommunal Creteil 65
Testing effectiveness (Phase 2)Study completedNCT01003106
What this trial is testing

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 81
Large-scale testing (Phase 3)Study completedNCT03223714
What this trial is testing

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 242
Early research (Phase 1)Study completedNCT00101764
What this trial is testing

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

Who this might be right for
Macular DegenerationRetinal Vein OcclusionDiabetic Retinopathy
National Eye Institute (NEI) 120
Large-scale testing (Phase 3)UnknownNCT04460001
What this trial is testing

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Who this might be right for
Ophthalmopathy
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT04740931
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein OcclusionHemiretinal Vein Occlusion
Hoffmann-La Roche 729
Early research (Phase 1)WithdrawnNCT03417401
What this trial is testing

Surgical Stabilizer Assisted RVC With rtPA for CRVO

Who this might be right for
Central Retinal Vein Occlusion
Universitaire Ziekenhuizen KU Leuven
Not applicableStudy completedNCT01568021
What this trial is testing

Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 100
Post-approval studies (Phase 4)Study completedNCT01870427
What this trial is testing

NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions

Who this might be right for
Macular Edema With Central Retinal Vein Occlusions
Northern California Retina Vitreous Associates 20
Not applicableEnded earlyNCT00379223
What this trial is testing

Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial

Who this might be right for
Retinal Vein Occlusion
University Hospital, Bordeaux 7
Testing effectiveness (Phase 2)Study completedNCT00088283
What this trial is testing

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Eyetech Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT02614937
What this trial is testing

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Ohr Pharmaceutical Inc. 20